Author:
Ashokkumar Chethan,Ganguly Bishu,Townsend Robert,White Jaimie,Levy Samantha,Moritz Michael,Mazariegos George,Sun Qing,Sindhi Rakesh
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Vincenti, F. et al. A Phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT Study). Am. J. Transplant. 10, 535–546 (2010).
2. Larsen, C. P. et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transplant. 5, 443–453 (2005).
3. Behar, S. M., Porcelli, S. A., Beckman, E. M. & Brenner, M. B. A pathway of costimulation that prevents anergy in CD28-T-cells: B7-independent costimulation of CD1-restricted T cells. J. Exp. Med. 182, 2007–2018(1995).
4. Croft, M., Bradley, L. M. & Swain, S. L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152, 2675–2685 (1994).
5. Lo, D. J. et al. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am. J. Transplant. 11, 22–33 (2011).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献